AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

IQVIA Inc. (IQV)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

193.74

0.30 (0.16%)

At close: Feb 18, 2025, 3:59 PM

193.15

-0.30%

After-hours: Feb 18, 2025, 04:11 PM EST

undefined% (undefined)

Bid	192
Market Cap	34.12B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	7.49
PE Ratio (ttm)	25.87
Forward PE	n/a
Analyst	Buy

Ask	214.49
Volume	747,302
Avg. Volume (20D)	1,451,261
Open	193.09
Previous Close	193.44
Day's Range	192.10 - 196.08
52-Week Range	187.62 - 261.73
Beta	undefined

About IQV

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation serv...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date May 9, 2013

Employees 88,000

Stock Exchange NYSE

Ticker Symbol IQV

Website https://www.iqvia.com

Full Company Profile

Analyst Forecast

According to 17 analyst ratings, the average rating for IQV stock is "Buy." The 12-month stock price forecast is $252.5, which is an increase of 30.33% from the latest price.

Buy 88.24%

Hold 11.76%

Sell 0.00%

Stock Forecasts

Next Earnings Release

IQVIA Inc. is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+2.2%

IQVIA Holdings shares are trading higher after the... Unlock content with Pro Subscription

2 months ago

+3%

IQVIA Holding shares are trading higher after Stephens & Co initiated coverage on the stock with an Overweight rating on the stock and announced a $250 price target.

News

1 day ago · zacks.com

NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight

ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management.

3 days ago · seekingalpha.com

IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way

IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and 2033, w...

4 days ago · zacks.com

IQVIA (IQV) International Revenue Performance Explored

Explore how IQVIA's (IQV) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

1 week ago · zacks.com

IQVIA Earnings & Revenues Surpass Estimates in Q4, Increase Y/Y

Growth in the Research and Development, and Technology and Analytics segments aids IQV's top line in the fourth quarter of 2024.

1 week ago · seekingalpha.com

IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript

IQVIA Holdings Inc. (NYSE:IQV ) Q4 2024 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Kerri Joseph – Senior Vice President, Investor Relations and Treasury Ari Bousbib – Ch...

1 week ago · benzinga.com

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions

On Thursday, IQVIA Holdings Inc IQV reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11.

1 week ago · zacks.com

Here's What Key Metrics Tell Us About IQVIA (IQV) Q4 Earnings

Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street ...

1 week ago · zacks.com

IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $3.12 per share, beating the Zacks Consensus Estimate of $3.10 per share. This compares to earnings of $2.84 per share a year ago.

1 week ago · reuters.com

IQVIA beats quarterly results estimates on analytics services demand

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

1 week ago · businesswire.com

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...

Load More News